140 related articles for article (PubMed ID: 10624817)
1. Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes.
Fleuranceau-Morel P; Barrier L; Fauconneau B; Piriou A; Huguet F
Neurosci Lett; 1999 Dec; 277(2):91-4. PubMed ID: 10624817
[TBL] [Abstract][Full Text] [Related]
2. Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes.
Morel P; Tallineau C; Pontcharraud R; Piriou A; Huguet F
Neurochem Int; 1998 Dec; 33(6):531-40. PubMed ID: 10098723
[TBL] [Abstract][Full Text] [Related]
3. Lactic acidosis progressively impairs dopamine uptake in rat striatal synaptosomes by a mechanism partially independent of the Na+/K+-ATPase dysfunction.
Barrier L; Barc-Pain S; Stadelmann-Ingrand S; Bestel E; Fauconneau B; Page G
Neurosci Lett; 2004 Apr; 359(1-2):114-8. PubMed ID: 15050724
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups.
Morel P; Fauconneau B; Page G; Mirbeau T; Huguet F
Neurosci Res; 1998 Oct; 32(2):171-9. PubMed ID: 9858024
[TBL] [Abstract][Full Text] [Related]
5. Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings.
Trejo F; Nekrassov V; Sitges M
Brain Res; 2001 Aug; 909(1-2):59-67. PubMed ID: 11478921
[TBL] [Abstract][Full Text] [Related]
6. Modeling of the interaction of Na+ and K+ with the binding of the cocaine analogue 3beta-(4-[125I]iodophenyl)tropane-2beta-carboxylic acid isopropyl ester to the dopamine transporter.
Chen NH; Ding JH; Wang YL; Reith ME
J Neurochem; 1997 May; 68(5):1968-81. PubMed ID: 9109523
[TBL] [Abstract][Full Text] [Related]
7. A new in vitro approach for investigating the MPTP effect on DA uptake.
Barc S; Page G; Fauconneau B; Barrier L; Huguet F
Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
[TBL] [Abstract][Full Text] [Related]
8. Contribution of lipid dynamics on the inhibition of bovine brain synaptosomal Na+-K+-ATPase activity induced by 4-hydroxy-2-nonenal.
Kadoya A; Miyake H; Ohyashiki T
Biol Pharm Bull; 2003 Jun; 26(6):787-93. PubMed ID: 12808287
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of xylamine on the uptake of [3H]dopamine into isolated striatal synaptosomes of the rats.
Liang P; Chang SS; Cheng JT
Neurosci Lett; 1993 Apr; 153(2):181-4. PubMed ID: 8392155
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
Midde NM; Gomez AM; Zhu J
J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
[TBL] [Abstract][Full Text] [Related]
12. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter mediated release of dopamine: role of chloride.
Sitges M; Reyes A; Chiu LM
J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.
Vaughan RA; Huff RA; Uhl GR; Kuhar MJ
J Biol Chem; 1997 Jun; 272(24):15541-6. PubMed ID: 9182590
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase.
Silva VS; Nunes MA; Cordeiro JM; Calejo AI; Santos S; Neves P; Sykes A; Morgado F; Dunant Y; Gonçalves PP
Toxicology; 2007 Jul; 236(3):158-77. PubMed ID: 17560001
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions with the dopamine transporter in cryopreserved human caudate.
Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
[TBL] [Abstract][Full Text] [Related]
17. Effects of mercuric chloride on [3H]dopamine release from rat brain striatal synaptosomes.
Hare MF; Minnema DJ; Cooper GP; Michaelson IA
Toxicol Appl Pharmacol; 1989 Jun; 99(2):266-75. PubMed ID: 2544041
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
Cowell RM; Kantor L; Hewlett GH; Frey KA; Gnegy ME
Eur J Pharmacol; 2000 Feb; 389(1):59-65. PubMed ID: 10686296
[TBL] [Abstract][Full Text] [Related]
19. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.
Bougria M; Vitorica J; Cano J; Machado A
Eur J Pharmacol; 1995 Nov; 291(3):407-15. PubMed ID: 8719427
[TBL] [Abstract][Full Text] [Related]
20. A model of the sodium dependence of dopamine uptake in rat striatal synaptosomes.
Wheeler DD; Edwards AM; Chapman BM; Ondo JG
Neurochem Res; 1993 Aug; 18(8):927-36. PubMed ID: 8371835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
